The week in GRC: Companies get new FCPA guidance, and cannabis firms face rising D&O insurance costs
– The Wall Street Journal reported that Elliott Management Corp is pressing Crown Castle International Corp to revamp its approach...
Regulatory & compliance archive
Alexion settles FCPA action for $21 million
Boston-based Alexion Pharmaceuticals has agreed to pay a total of more than $21 million to settle SEC allegations that it violated...
DoJ shines new light on compliance program expectations
On June 1, 2020, the US Department of Justice’s (DoJ) criminal division issued updated guidance on the ‘Evaluation of corporate...
Boards urged to review policies after LGBTQ ruling
Boards of directors have been advised to ensure their company’s anti-discrimination policies are checked following a recent US...
CCPA regulations pose new compliance hurdles as enforcement approaches
California Attorney General Xavier Becerra’s enforcement of the California Consumer Privacy Act of 2018 (CCPA) is likely to begin...
The week in GRC: Pandemic puts squeeze on compliance teams, and whistleblower attorneys see boom
– CNBC reported that the NYSE trading floor, which had been closed since March 23 as a result of the Covid-19 pandemic, partially...
BIOMIN America settles Cuba sanctions case
Overland Park, Kansas-based BIOMIN America has paid $257,862 to settle its potential civil liability for ‘apparent violations’ of...
CalPERS raises concerns over MD&A reform plans
CalPERS has voiced concerns that SEC disclosure reforms would leave investors lacking key information – and raise particular...
Rule 14a-8 reforms would halt many resubmissions, CII argues
A new paper from the Council of Institutional Investors (CII) argues that parts of the SEC’s proposed changes to Rule 14a-8 would...
The week in GRC: Warren seeks to curb M&A during pandemic, and SEC creates Covid-19 monitoring group
– The SEC has created an internal, cross-divisional Covid-19 market monitoring group. The temporary group will help the commission...
